Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;33(4):e13776.
doi: 10.1111/dth.13776. Epub 2020 Jul 3.

Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy

Pamela Vezzoli  1 , Marco Di Mercurio  1 , Andrea Carugno  1 , Daniele Mario Gambini  1 , Elisa Robustelli Test  2 , Gianlorenzo Imberti  1 , Angelo Francesco Castagna  1 , Paolo Sena  1
Affiliations

Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy

Pamela Vezzoli et al. Dermatol Ther. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Torres T, Puig L. Managing cutaneous immune‐mediated diseases during the COVID‐19 pandemic. Am J Clin Dermatol. 2020;21(3):307‐311. 10.1007/s40257-020-00514-2 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Rademaker M, Baker C, Foley P, Sullivan J, Wang C. Advice regarding COVID‐19 and use of immunomodulators, in patients with severe dermatological diseases. Australas J Dermatol. 2020;61(2):158‐159. 10.1111/ajd.13295 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Mathian A, Mahevas M, Rohmer J, et al. Clinical course of coronavirus disease 2019 (COVID‐19) in a series of 17 patients with systemic lupus erythematosus under long‐term treatment with hydroxychloroquine. Ann Rheum Dis. 2020;79(6):837‐839. 10.1136/annrheumdis-2020-217566 [Epub ahead of print]. - DOI - PubMed
    1. Konig MF, Kim AH, Scheetz MH, et al. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS‐CoV‐2 infection and severe COVID‐19. Ann Rheum Dis. 2020. 10.1136/annrheumdis-2020-217690 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Sawalha AH, Manzi S. Coronavirus disease‐2019: implication for the care and management of patients with systemic lupus erythematosus. Eur J Rheumatol. 2020. 10.5152/eurjrheum.2020.20055 [Epub ahead of print]. - DOI - PMC - PubMed